aTyr Pharma, Inc.ATYRNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+136.9%
5Y CAGR+5.4%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+136.9%/yr
vs +22.8%/yr prior
5Y CAGR
+5.4%/yr
Recent acceleration
Acceleration
+114.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $22.52M | - |
| 2024 | $0.00 | - |
| 2023 | $0.00 | -100.0% |
| 2022 | $1.70M | +30.0% |
| 2021 | $1.30M | -92.5% |
| 2020 | $17.29M | +23.1% |
| 2019 | $14.05M | +1783.1% |
| 2018 | $746000.00 | +4.6% |
| 2017 | $713000.00 | -20.8% |
| 2016 | $900000.00 | - |